2006
DOI: 10.1196/annals.1326.003
|View full text |Cite
|
Sign up to set email alerts
|

The Intestinal Microvasculature as a Therapeutic Target in Inflammatory Bowel Disease

Abstract: Chronic inflammation is a complex biologic process which involves immune as well as non-immune cells including the microvasculature and its endothelial lining. Growing evidence suggests that the microvasculature plays an integral role in the pathophysiology of inflammatory bowel disease (IBD; Crohn's disease and ulcerative colitis). The microvasculature contributes to chronic inflammation through altered leukocyte recruitment, impaired perfusion, and angiogenesis leading to tissue remodeling. These diverse are… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
60
0
1

Year Published

2008
2008
2018
2018

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 77 publications
(63 citation statements)
references
References 145 publications
(233 reference statements)
1
60
0
1
Order By: Relevance
“…Although the effects of CB-01-05 on cytokines production are in agreement with the known ability of dalteparin and other heparin derivatives to influence cytokines production and to arrest immune inflammation in rodents [16,17,25], we cannot exclude the involvement of additional mechanisms. Among these putative mechanisms increase of expression of some growth factors [26], decrease of nitric oxide synthesis [18,20,27], as well as effects on intestinal microcirculation [12,28], and leucocyte-endothelial interactions [19] could be involved in the activity of CB-01-05. On the other hand, the observation that macroscopic mucosal haemorrhages were not severer in CB-01-05 group than in the control groups suggests that the local activity of CB-01-05 is not mediated by a direct anticoagulant mechanism.…”
Section: Discussionmentioning
confidence: 99%
“…Although the effects of CB-01-05 on cytokines production are in agreement with the known ability of dalteparin and other heparin derivatives to influence cytokines production and to arrest immune inflammation in rodents [16,17,25], we cannot exclude the involvement of additional mechanisms. Among these putative mechanisms increase of expression of some growth factors [26], decrease of nitric oxide synthesis [18,20,27], as well as effects on intestinal microcirculation [12,28], and leucocyte-endothelial interactions [19] could be involved in the activity of CB-01-05. On the other hand, the observation that macroscopic mucosal haemorrhages were not severer in CB-01-05 group than in the control groups suggests that the local activity of CB-01-05 is not mediated by a direct anticoagulant mechanism.…”
Section: Discussionmentioning
confidence: 99%
“…Biological agents targeting adhesion molecules and chemokines to reduce leukocyte infiltration and inflammatory responses, modulation of coagulation pathways, angiogenesis inhibition, and reversal of microvascular dysfunction are all currently areas of intense study with the goal to rapidly expand our therapeutic armamentarium for IBD therapy and to translate bench research and conquests to the patient bedside. 105 …”
Section: Discussionmentioning
confidence: 99%
“…This process likely results in an excessive cytotoxic response (15,16), increased permeability of the epithelial barrier (17,18), continuous epithelial erosion, and reduced production of defensins (19). In turn, commensal bacteria cross the epithelial cell layer (20), leading to an accelerated activation of effector T cells (21) and increased recruitment of inflammatory cells into the intestinal mucosa (22).…”
mentioning
confidence: 99%